Press releases

Advanced Search
  • Aug 27, 2015
    Commitments include cash and product donations through AmeriCares, Direct Relief, Heart to Heart International, Project HOPE, Save the Children and UNICEF

    FRANKLIN LAKES, N.J., Aug. 27, 2015 – BD (Becton, Dickinson and Company), a leading global medical technology company, has committed $700,000 in aid to assist those affected by the April 2015...

  • Aug 25, 2015

    FRANKLIN LAKES, N.J., Aug. 25, 2015 – BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed...

  • Aug 6, 2015
    - Announces adjusted revenues of $3.133 billion, an increase of 45.2 percent, or 55.6 percent on a currency-neutral basis. On a comparable, currency-neutral basis, adjusted revenues grew 2.4 percent. As reported, revenues of $3.120 billion increased 44.6 percent.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly adjusted revenues of $3.133 billion for the third fiscal quarter ended June...

  • Jul 28, 2015

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 60 cents per common share, payable on September 30, 2015 to holders of record on...

  • Jul 13, 2015
    2014 Sustainability Report outlines new integrated strategy and goals to create more sustainable healthcare solutions

    FRANKLIN LAKES, N.J., July 13, 2015 – BD(Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today an updated sustainability strategy and goals for...